Table of Content

S-1
Title page S-2 Contents page S-3 Figure S1 . LC-MS data of crude reaction mixture (Protein 1) (LCT) S-4 Figure S2 : MS analysis of 5-TAMRA-Lys(mISG15)-Gly-OH (XEVO).
S-5
Scheme S1: Synthesis of Rho-mISG15-PA probe (2) .
S-6 Figure S3 : 
S5
Scheme S1. Synthesis of Rho-mISG15-PA probe (2) Figure S6 . Assessment of Rhodamine-mISG15-PA reactivity against endogenous mUSP18. Corresponding fluorescence scan, full immunoblots for labelling of endogenous mUSP18 in mouse NMuMG cell lysates. The labelled samples were resolved in SDS-PAGE gel, and scanned in Rhodamine channel for probe signal, then the gel was transferred to Nitrocelluse membrane, and immunobloted against anti-mUSP18, anti-mISG15 and antiβ-Actin antibodies sequentially. 
Chemical Synthesis
LC-MS analysis (LCT)
HRMS-measurements(XEVO)
High resolution mass spectra were recorded on a Waters Acquity H-class UPLC with XEVO-G2 XS Q-TOF mass spectrometer equipped with an electrospray ion source in positive mode (source voltage 3. 
HPLC purification
HPLC purifications were carried out on a Waters HPLC equipped with a Waters 2489 UV/Vis detector, Waters fraction collector III and Waters XBridge prep C8 OBD column (250 × 22 mm, 10 µm). Flow rate = 37.5 mL min -1 . Mobile phase: A = H 2 O, B = CH 3 CN and C = 1% TFA in H 2 O. Gradient: 0-5 min: 90% A, 5% B, 5%C; 5-7 min :5 → 20% B, 5% C; 7-18 min: 20 → 45% B, 5% C; 18-18.5 min: 45 → 95% B, 5% C; 18.5-21.6 min: 95% B, 5% C; 21.6-25 min: 95% → 5% B, 5% C.
Solid Phase Peptide Synthesis
Synthesis of the C-terminal domain SPPS was carried out on a Syro II MultiSyntech Automated Peptide synthesizer using standard 9fluorenylmethoxycarbonyl (Fmoc)-based solid phase peptide chemistry at 25 μmol scale. The coupling condition is fourfold excess of amino acids relative to pre-loaded Fmoc-L-Gly-PEG-PS resin (0.18 mmol/g) or Fmoc-L-Gly-Trityl-TentaGel resin (0.18 mmol/g). Double couplings were performed in NMP for 45 min with PyBOP (4 eq.) and DiPEA (8 eq.). The following protected pseudoproline building blocks were incorporated during the synthesis as indicated in Figure 1 : Fmoc-L-Gln(Trt)-L-Thr(psiMe,Mepro)-OH, Fmoc-L-Val-L-Ser(psiMe,Mepro)-OH and Fmoc-L-Leu-L-Ser(psiMe,Mepro)-OH. All amino acid and dipeptide building blocks were dried overnight under high vacuum before usage. Fmoc was removed with 20% piperidine in NMP (3×1.2 mL, 2×2 and 1×5 min). After the synthesis was finished, the resin was washed with Et 2 O, dried under high vacuum and stored for further use. An initial trial cleavage using a small amount of the resin was performed to access the quality of the crude proteins (analysis data can be found in Figure S7 & S10 ).
Synthesis of the N-terminal domain
S18 SPPS was carried out on an Intavis MultiPep CF peptide synthesizer using standard 9fluorenylmethoxycarbonyl (Fmoc)-based solid phase peptide chemistry on a 50 μmol scale and the synthesis was optimized by following the Fmoc cleavage with the Intavis. The coupling condition is fourfold excess of amino acids relative to pre-loaded Fmoc-L-Gln(Trt)-Trityl-TentaGel resin (0.16 mmol/g). Double couplings were performed in NMP for 45 min with PyBOP (4 eq.) and DiPEA (16 eq.). The following protected pseudoproline building blocks were incorporated during the synthesis as indicated in Figure 1 The resin (5, 25 µmol) was rinsed two times with DCM and then treated with 20% hexafluoroisopropanol (HFIP) in DCM (v/v; 2× 20 min). The combined filtrates were concentrated under reduced pressure and the residue was co-evaporated with DCE (3×) and lyophilized overnight to give crude protein 6. The protected protein (6) was dissolved in chloroform (30 mL) and the reaction mixture was cooled to -18 ºC. The 2,2,2-trifluroethanol (10 mL) was added, followed by the addition of HCl·H-Gly-S(CH 2 ) 2 CO 2 Me (7) (3 eq.), EDC (3.0 eq.) and HOBt (3.0 eq.) and the reaction was stirred overnight. An initial trial cleavage using a small amount of the reaction mixture was performed to check the reaction and LC/MS data shows a good conversion of the starting material. 
Native chemical ligation
Full-length mISG15 (1) The mISG15-thioester peptide (9) (10.5 mg) was first dissolved in 200 µL of buffer containing 8.0 M Gnd·HCl and 0.2 M Na 2 HPO 4 at pH 7.5. The C-terminal peptide (4) (15.2 mg) was dissolved in 300 μL of the same buffer, followed by the addition of 100 μL MPAA (1M) and this solution was pre-incubated for 5 minutes. These two solutions were properly mixed and the pH of the reaction mixture was adjusted to pH 7.5 by the addition of 10% Na 2 CO 3 solution. The reaction mixture was shaken overnight at 37 °C. LC-MS analysis showed complete consumption of the peptide 9. The crude product was purified by Waters HPLC. Pure fractions were combined and lyophilized. The obtained protein was further dissolved in H 2 O/CH 3 CN/formic acid (65/25/10; v/v/v) and lyophilized three times. The desired product was obtained as a white solid. The protein was further purified by gel filtration on a Sephadex S75 16/60 PG column (GE Healthcare), using a 100 mM MES, 200 mM NaCl, 10% Glycerol buffer at pH 6.5. The pure protein was kept in the buffer for further experiments. Protein concentration was determined (method is described in biochemical experiments part) and then the total amount of protein was calculated. Rho-mISG15-PA probe (2) This probe was prepared in the same way as described for the synthesis of full length mISG15 (1), using Rho-mISG15-thioester peptide (18, 5.2 mg) and C-terminal peptide (14, 11.1 mg). After purification by Waters HPLC, a solid was obtained. The product was further purified by gel filtration and kept in buffer for further experiments. Protein concentration was determined (method is described in biochemical experiments part) and then the total amount of protein was calculated. 
Protein concentration measurements
The protein concentration of synthetic mISG15 and its probe was quantified in SDS-PAGE gel bands using ImageJ software (NIH), with expressed ubiquitin (a range from 0.1 µg/µL to 1 µg/µL) being used for the standard curve.
E1-mediated native chemical ligation of mISG15 withthiolysine modified peptide
The expressed mISG15 wildtype protein was purified from E.coli as described previously. 1 hours. Next, 10 µL of the crude ligation mixture was added to LDS (lithium dodecyl sulfate) sample buffer (Invitrogen Life Technologies, Carlsbad, CA, USA) containing 2.5% β-mercaptoethanol, followed by boiling for 7 minutes. Samples were resolved on a 12% Bis-Tris NuPAGE Gel (Invitrogen) using MES buffer (Invitrogen Life Technologies, Carlsbad, CA, USA). Labelled mISG15 was visualized by in-gel fluorescence using a Typhoon FLA 9500 imaging system (GE Healthcare Life Sciences) (TAMRA channel for labelled mISG15, Cy5 channel for protein marker). The gel was then stained with InstantBlue (Expedeon). For LC-MS detection, the crude ligation mixture was pre-treated with TCEP (final concentration 2 mM) for 10 minutes.
